Yunhai Feng

Dr. Yunhai Feng


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
JZJing Zhou
Jing Zhou
YLYi Lu
Yi Lu
WWWei Wu
Wei Wu
YFYunhai Feng
Yunhai Feng
Background. Allergic rhinitis (AR) is a global disease without specific treatment. Human mesenchymal stem cell- (HMSC-) derived exosomes (HMSC-exos) have been implicated for the amelioration of allergic inflammation by delivering miR-146a-5p in a mouse asthma model. However, the antiallergic activity and the underlying mechanism of HMSC-exos in AR remain unclear. The present study aimed to investigate the role of HMSC-exos in the pathogenesis of AR. Materials and Methods. Blood specimens were collected from AR patients and healthy donators for investigation. HMSC and CD4+ T cells were used in the present study. Flow cytometry was used to characterize the population of Type 1 helper T (Th1) and Th2 cells. Specific siRNA and overexpressed plasmids were designed to silence or overexpress the expressions of miR-146a-5p and SERPINB2. Luciferase reporter assay was adopted to explore the binding site of miR-146a-5p and SERPINB2. Quantitative real-time PCR and immunoblots were performed to estimate the expression of target genes. Results. The population of Th2 cells was significantly elevated in AR patients as compared with that in healthy donators. HMSC-exos could decrease the expression of SERPINB2 and the differentiation of Th2 cells. miR-146a-5p in HMSC-exos exhibited consistent effects and lowered the expression of SERPINB2 by binding on its 3UTR region. Moreover, the differentiation of Th2 cells was promoted by SERPINB2 that could be reversed by HMSC-exos. Additionally, the miR-146a-5p expression was negatively associated with the SERPINB2 expression in the serum of AR patients. Conclusion. HMSC-exos could inhibit the differentiation of Th2 cells via the regulation of the miR-146a-5p/SERPINB2 pathway. miR-146a-5p and SERPINB2 could be applied as potential targets for AR treatment.

3 October 2024 in The International Journal of Robotics Research
Verified
Journal Article
Closed access
JLJun Lv
Jun Lv
YFYunhai Feng
Yunhai Feng
CZCheng Zhang
Cheng Zhang
SZShuang Zhao
Shuang Zhao
LSLin Shao
Lin Shao
CLCewu Lu
Cewu Lu
Model-based reinforcement learning is recognized with the potential to be significantly more sample efficient than model-free reinforcement learning. How an accurate model can be developed automatically and efficiently from raw sensory inputs (such as images), especially for complex environments and tasks, is a challenging problem that hinders the broad application of model-based reinforcement learning in the real world. In this work, we propose a sensing-aware model-based reinforcement learning system called SAM-RL. Leveraging the differentiable physics-based simulation and rendering, SAM-RL automatically updates the model by comparing rendered images with real raw images and produces the policy efficiently. With the sensing-aware learning pipeline, SAM-RL allows a robot to select an informative viewpoint to monitor the task process. We apply our framework to real world experiments for accomplishing three manipulation tasks: robotic assembly, tool manipulation, and deformable object manipulation. We demonstrate the effectiveness of SAM-RL via extensive experiments. Videos are available on our project webpage.

19 June 2021 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
YFYunhai Feng
Yunhai Feng
YLYi Lu
Yi Lu
WWWei Wu
Wei Wu
YFYunhai Feng
Yunhai Feng
Background: Allergic rhinitis (AR) is one of the most widespread immune conditions worldwide. However, common treatments often present with significant side effects or are cost-prohibitive for much of the population. A plethora of treatments have been used for the treatment of AR including antihistamines, steroids, and immune modulators. Among the treatments which have shown potential for efficacy in treating AR with a minimum of side effects but remains understudied is the conditionally essential amino acid taurine. Taurine has been previously shown to reduce AR symptoms. Here, we examine the role of taurine in modulating T regulatory cells, modulating the cytokine response in AR, and restoring healthy nasal mucosa. Methods: Blood samples from 20 healthy donors and 20 AR patients were compared for CD4+CD25+FoxP3+ T regulatory (Treg) cell population percentage, cytokine release, and STAT1 signaling with and without taurine treatment or IL-35 neutralization. An OVA-induced AR mouse model was administered vehicle, taurine, or taurine plus an IL-35 neutralizing antibody and assayed for sneezing frequency, inflammatory cytokine response, nasal mucosa goblet cell density, and T regulatory cell percentage. CD4+ cells were further examined for cytokine release, STAT1 phosphorylation, and response to an anti-IL-35 antibody with and without a STAT1 inhibitor. Results: Comparison of blood from normal donors and AR patients showed a reduction in CD4+CD25+FoxP3+ Treg cells in AR patients and a strong correlation between Treg percentage and IL-35 release. A similar pattern of Treg suppression was found in untreated AR mice when compared to normal control mice wherein there was a reduction in Treg percentage and a corresponding decrease in IL-35 release. AR mice also demonstrated increased sneezing frequency, an infiltration of goblet cell in nasal mucosa, and a reduction in IL-35 release from CD4+ cells. Conversely, IL-4, IL-5, and IL-13 secretion from CD4+ cells were increased in AR model mice, as was STAT1 phosphorylation. When AR mice were treated with taurine, sneezing frequency and nasal mucosa goblet cell content were reduced while Treg abundance was increased to that of normal mice. Accordingly, IL-35 release was restored, while IL-4, IL-5, and IL-13 secretion from CD4+ cells were suppressed. Likewise, STAT1 phosphorylation was inhibited with taurine treatment. Taurine-treated mice also given an IL-35 neutralizing antibody exhibited AR pathology including frequent sneezing and high nasal goblet cell content while retaining a restoration of Tregs. Furthermore, murine AR model CD4+ cells exposed to recombinant IL-35 responded with a reduction in inflammatory cytokine release and a decrease in STAT1 phosphorylation, mimicking the effect of taurine treatment. Conclusions: Taurine induces release of IL-35 in AR; IL-35 promotes the production of CD4+CD25+FoxP3+ Treg cells via a STAT1-dependent pathway. The restoration of Treg populations by taurine normalizes the inflammatory response, reduces AR symptomology, and reduces histopathologic signs of AR.

5 September 2024 in IEEE Transactions on Robotics
Verified
Journal Article
Closed access
SYShenli Yuan
Shenli Yuan
LSLin Shao
Lin Shao
YFYunhai Feng
Yunhai Feng
JSJiatong Sun
Jiatong Sun
TXTeng Xue
Teng Xue
JSJ. Kenneth Salisbury
J. Kenneth Salisbury
Robot in-hand manipulation is an important skill for robots to carry out sophisticated tasks that require moving the grasped object within hand. In this work, we present the Roller Grasper V3, a non-anthropomorphic robot grasper with a steerable roller on each of its four fingertips, and a manipulation architecture that enables the Roller Grasper V3 to achieve full 6-DoF manipulation of the grasped object in $SE(3)$ . The manipulation architecture consists of a high-level planner that searches for a feasible path with waypoints for the object to be manipulated, and a low-level control policy that is used to navigate the object in between the adjacent waypoints. The method was experimentally validated on the Roller Grasper V3 to manipulate multiple objects with different geometries and topologies.

27 February 2023 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
JYJundong Yang
Jundong Yang
WXWenjun Xue
Wenjun Xue
ZWZhicheng Wei
Zhicheng Wei
CHCaiqiong Hou
Caiqiong Hou
HZHuaming Zhu
Huaming Zhu
XLXinyi Li
Xinyi Li
Objectives. Obstructive sleep apnoea (OSA) is associated with an increased risk of cardiovascular disease, with alterations in coagulability suspected as the mediating factor. This study explored blood coagulability and breathing-related parameters during sleep in patients with OSA. Design. Cross-sectional observational study. Setting. Shanghai Sixth People’s Hospital. Participants. 903 patients diagnosed by standard polysomnography. Main Outcome and Measures. The relationships between coagulation markers and OSA were evaluated using Pearson’s correlation, binary logistic regression, and restricted cubic spline (RCS) analyses. Results. The platelet distribution width (PDW) and activated partial thromboplastin time (APTT) decreased significantly with increasing OSA severity (both ). PDW was positively associated with the apnoea-hypopnea index (AHI), oxygen desaturation index (ODI), and microarousal index (MAI) (ß = 0.136, ; ß = 0.155, ; and ß = 0.091, , respectively). APTT was negatively correlated with AHI (ß = −0.128, ) and ODI (ß = −0.123, ). PDW was negatively correlated with percentage of sleep time with oxygen saturation below 90%(CT90) (ß = −0.092, ). The minimum arterial oxygen saturation (SaO2) correlated with PDW (ß = −0.098, ), APTT (ß = 0.088, ), and prothrombin time (PT) (ß = 0.106, ). ODI was risk factors for PDW abnormalities (odds ratio (OR) = 1.009, ) after model adjustment. In the RCS, a nonlinear dose-effect relationship was demonstrated between OSA and the risk of PDW and APTT abnormalities. Conclusion. Our study revealed nonlinear relationships between PDW and APTT, and AHI and ODI, in OSA, with AHI and ODI increasing the risk of an abnormal PDW and thus also the cardiovascular risk. This trial is registered with ChiCTR1900025714.

15 May 2020 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
JZJing Zhou
Jing Zhou
YLYi Lu
Yi Lu
FLFengqian Li
Fengqian Li
Wei WuWei Wu
Wei Wu
DXDonghao Xie
Donghao Xie
YFYunhai Feng
Yunhai Feng
Background: The current treatment for allergic rhinitis (AR) is inadequate. Objective: The present study aimed to investigate the therapeutic effect of taurine on AR and to identify the underlying molecular mechanisms. Methods: The serum level of the antioxidant enzyme extracellular superoxide dismutase (SOD3) was determined in AR patients and in healthy controls. The antiallergic inflammatory effects of taurine were evaluated in a dinitrophenyl-human serum albumin (DNP-HSA)-stimulated human mast cell line (HMC-1) and in an ovalbumin (OVA)-induced AR mouse model. Results: Clinically, a reduction in serum level of SOD3 was observed in AR patients. Taurine treatment led to dose-dependent increases in SOD3 at both protein and mRNA levels in HMC-1 cells. SOD3 production was regulated by peroxisome proliferator-activated receptor-γ (PPAR-γ) in response to taurine. SOD3 overexpression inhibited the release of proinflammatory cytokines including tumor necrosis factor-α (, interleukin (IL)-4, and IL-6. Its overexpression also ameliorated the loss of interferon-γ. SOD3 and PPAR-γ influenced inflammatory cytokine production via regulation of the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2). An OVA-induced AR animal model study showed that taurine was efficacious in alleviating allergic inflammatory reactions by relieving behavior symptoms of AR mice and reducing eosinophilic and mast cell infiltration into the nasal cavity. In addition, taurine treatment increased the production of SOD3 and PPAR-γ, which, in turn, suppressed expression of proinflammatory cytokines through phosphorylation of ERK1/2. Conclusion: Taurine could potentially serve as a therapeutic treatment for allergic disorders.